Annual EBIT:
$23.02M+$13.20M(+134.41%)Summary
- As of today, LGND annual earnings before interest & taxes is $23.02 million, with the most recent change of +$13.20 million (+134.41%) on December 31, 2024.
- During the last 3 years, LGND annual EBIT has fallen by -$43.23 million (-65.25%).
- LGND annual EBIT is now -85.94% below its all-time high of $163.73 million, reached on December 31, 2018.
Performance
LGND EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$12.38M+$61.69M(+125.10%)Summary
- As of today, LGND quarterly earnings before interest & taxes is $12.38 million, with the most recent change of +$61.69 million (+125.10%) on June 30, 2025.
- Over the past year, LGND quarterly EBIT has increased by +$76.50 million (+119.30%).
- LGND quarterly EBIT is now -98.55% below its all-time high of $851.62 million, reached on March 31, 2019.
Performance
LGND Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$80.85M+$76.50M(+48.62%)Summary
- As of today, LGND TTM earnings before interest & taxes is -$80.85 million, with the most recent change of +$76.50 million (+48.62%) on June 30, 2025.
- Over the past year, LGND TTM EBIT has dropped by -$135.40 million (-248.21%).
- LGND TTM EBIT is now -107.97% below its all-time high of $1.01 billion, reached on March 31, 2019.
Performance
LGND TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
LGND EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +134.4% | +119.3% | -248.2% |
| 3Y3 Years | -65.3% | +36.0% | -289.0% |
| 5Y5 Years | +502.4% | -64.0% | -1139.1% |
LGND EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -65.3% | +134.4% | -89.1% | +119.3% | -166.2% | +48.6% |
| 5Y | 5-Year | -65.3% | +502.4% | -89.1% | +119.3% | -166.2% | +48.6% |
| All-Time | All-Time | -85.9% | +133.1% | -98.5% | +116.9% | -108.0% | +48.6% |
LGND EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $12.38M(+125.1%) | -$80.85M(+48.6%) |
| Mar 2025 | - | -$49.31M(-28.7%) | -$157.35M(-2934.6%) |
| Dec 2024 | $23.02M(+134.4%) | -$38.32M(-584.5%) | $5.55M(-90.9%) |
| Sep 2024 | - | -$5.60M(+91.3%) | $61.10M(+12.0%) |
| Jun 2024 | - | -$64.12M(-156.5%) | $54.55M(-55.3%) |
| Mar 2024 | - | $113.59M(+559.3%) | $122.13M(+89.9%) |
| Dec 2023 | $9.82M(-23.5%) | $17.23M(+241.9%) | $64.32M(-10.0%) |
| Sep 2023 | - | -$12.14M(-451.5%) | $71.47M(-25.8%) |
| Jun 2023 | - | $3.46M(-93.8%) | $96.30M(-5.5%) |
| Mar 2023 | - | $55.78M(+128.8%) | $101.94M(+169.6%) |
| Dec 2022 | $12.84M(-80.6%) | $24.38M(+92.2%) | $37.81M(+5.7%) |
| Sep 2022 | - | $12.69M(+39.4%) | $35.78M(-16.4%) |
| Jun 2022 | - | $9.10M(+208.9%) | $42.79M(-40.5%) |
| Mar 2022 | - | -$8.36M(-137.4%) | $71.87M(-21.7%) |
| Dec 2021 | $66.25M(+658.8%) | $22.35M(+13.4%) | $91.82M(+0.8%) |
| Sep 2021 | - | $19.70M(-48.4%) | $91.06M(+37.9%) |
| Jun 2021 | - | $38.18M(+229.3%) | $66.02M(+6.2%) |
| Mar 2021 | - | $11.60M(-46.3%) | $62.17M(+116.6%) |
| Dec 2020 | $8.73M(+252.6%) | $21.59M(+504.0%) | $28.71M(+268.9%) |
| Sep 2020 | - | -$5.34M(-115.6%) | $7.78M(+246.4%) |
| Jun 2020 | - | $34.33M(+257.0%) | $2.25M(+105.5%) |
| Mar 2020 | - | -$21.87M(-3418.2%) | -$41.10M(-104.9%) |
| Dec 2019 | -$5.72M(-103.5%) | $659.00K(+106.1%) | $832.38M(+4.7%) |
| Sep 2019 | - | -$10.88M(-20.7%) | $795.08M(-11.3%) |
| Jun 2019 | - | -$9.02M(-101.1%) | $896.38M(-11.6%) |
| Mar 2019 | - | $851.62M(+2423.9%) | $1.01B(+357.8%) |
| Dec 2018 | $163.73M(+140.5%) | -$36.65M(-140.5%) | $221.60M(-24.2%) |
| Sep 2018 | - | $90.43M(-17.1%) | $292.35M(+34.5%) |
| Jun 2018 | - | $109.03M(+85.5%) | $217.38M(+81.2%) |
| Mar 2018 | - | $58.79M(+72.4%) | $119.99M(+68.0%) |
| Dec 2017 | $68.08M(+51.6%) | $34.10M(+120.6%) | $71.41M(+112.6%) |
| Sep 2017 | - | $15.46M(+32.8%) | $33.59M(+42.3%) |
| Jun 2017 | - | $11.64M(+13.9%) | $23.59M(+48.2%) |
| Mar 2017 | - | $10.22M(+374.0%) | $15.92M(-23.5%) |
| Dec 2016 | $44.92M(+58.4%) | -$3.73M(-168.2%) | $20.80M(-40.2%) |
| Sep 2016 | - | $5.47M(+37.7%) | $34.76M(-9.1%) |
| Jun 2016 | - | $3.97M(-73.7%) | $38.24M(-1.6%) |
| Mar 2016 | - | $15.10M(+47.6%) | $38.85M(+42.2%) |
| Dec 2015 | $28.35M(+36.9%) | $10.23M(+14.4%) | $27.33M(+0.1%) |
| Sep 2015 | - | $8.94M(+95.1%) | $27.30M(+23.7%) |
| Jun 2015 | - | $4.58M(+28.3%) | $22.07M(+16.3%) |
| Mar 2015 | - | $3.57M(-65.0%) | $18.98M(-8.4%) |
| Dec 2014 | $20.71M(+29.6%) | $10.20M(+174.6%) | $20.71M(+20.8%) |
| Sep 2014 | - | $3.71M(+148.6%) | $17.14M(+2.5%) |
| Jun 2014 | - | $1.49M(-71.8%) | $16.72M(-3.2%) |
| Mar 2014 | - | $5.30M(-20.0%) | $17.27M(+8.0%) |
| Dec 2013 | $15.98M(+1697.9%) | $6.63M(+101.0%) | $15.98M(+14.3%) |
| Sep 2013 | - | $3.30M(+61.8%) | $13.98M(+48.4%) |
| Jun 2013 | - | $2.04M(-49.3%) | $9.43M(+57.4%) |
| Mar 2013 | - | $4.02M(-13.1%) | $5.99M(+392.8%) |
| Dec 2012 | $889.00K(+735.0%) | $4.63M(+467.1%) | $1.22M(-21.3%) |
| Sep 2012 | - | -$1.26M(+10.0%) | $1.54M(+9.5%) |
| Jun 2012 | - | -$1.40M(-86.3%) | $1.41M(-56.0%) |
| Mar 2012 | - | -$752.00K(-115.2%) | $3.20M(+1086.7%) |
| Dec 2011 | -$140.00K(+98.8%) | $4.96M(+455.4%) | $270.00K(+104.3%) |
| Sep 2011 | - | -$1.40M(-455.0%) | -$6.26M(+61.6%) |
| Jun 2011 | - | $393.00K(+110.7%) | -$16.29M(+0.3%) |
| Mar 2011 | - | -$3.69M(-135.1%) | -$16.33M(-6.4%) |
| Dec 2010 | -$11.36M(+29.6%) | -$1.57M(+86.3%) | -$15.35M(-20.5%) |
| Sep 2010 | - | -$11.43M(-3383.9%) | -$12.73M(-5532.7%) |
| Jun 2010 | - | $348.00K(+112.9%) | -$226.00K(+95.5%) |
| Mar 2010 | - | -$2.70M(-357.6%) | -$5.01M(+47.8%) |
| Dec 2009 | -$16.14M | $1.05M(-2.7%) | -$9.60M(+88.6%) |
| Sep 2009 | - | $1.08M(+124.3%) | -$84.07M(+8.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2009 | - | -$4.43M(+39.2%) | -$91.50M(+1.3%) |
| Mar 2009 | - | -$7.29M(+90.1%) | -$92.70M(+4.3%) |
| Dec 2008 | -$27.04M(+50.8%) | -$73.43M(-1055.4%) | -$96.86M(-303.2%) |
| Sep 2008 | - | -$6.36M(-12.8%) | -$24.02M(+9.0%) |
| Jun 2008 | - | -$5.63M(+50.8%) | -$26.39M(+24.9%) |
| Mar 2008 | - | -$11.45M(-1846.6%) | -$35.12M(+33.4%) |
| Dec 2007 | -$54.94M(-50.1%) | -$588.00K(+93.3%) | -$52.72M(+30.1%) |
| Sep 2007 | - | -$8.72M(+39.3%) | -$75.39M(+15.4%) |
| Jun 2007 | - | -$14.37M(+50.5%) | -$89.12M(+4.0%) |
| Mar 2007 | - | -$29.04M(-24.9%) | -$92.81M(-18.9%) |
| Dec 2006 | -$36.61M(-38.3%) | -$23.26M(-3.6%) | -$78.08M(+0.4%) |
| Sep 2006 | - | -$22.45M(-24.3%) | -$78.38M(-29.5%) |
| Jun 2006 | - | -$18.06M(-26.2%) | -$60.52M(-23.6%) |
| Mar 2006 | - | -$14.31M(+39.2%) | -$48.97M(+2.9%) |
| Dec 2005 | -$26.47M(+29.2%) | -$23.56M(-413.4%) | -$50.42M(-535.9%) |
| Sep 2005 | - | -$4.59M(+29.5%) | $11.57M(+1995.8%) |
| Jun 2005 | - | -$6.51M(+58.7%) | $552.00K(+104.6%) |
| Mar 2005 | - | -$15.77M(-141.0%) | -$12.07M(+21.5%) |
| Dec 2004 | -$37.37M(-94.9%) | $38.44M(+346.3%) | -$15.38M(+84.3%) |
| Sep 2004 | - | -$15.61M(+18.4%) | -$98.00M(-8.2%) |
| Jun 2004 | - | -$19.13M(-0.2%) | -$90.59M(-12.5%) |
| Mar 2004 | - | -$19.08M(+56.8%) | -$80.54M(-8.8%) |
| Dec 2003 | -$19.18M(+20.6%) | -$44.19M(-439.3%) | -$74.02M(-34.4%) |
| Sep 2003 | - | -$8.19M(+9.7%) | -$55.07M(-2.6%) |
| Jun 2003 | - | -$9.07M(+27.8%) | -$53.66M(+0.7%) |
| Mar 2003 | - | -$12.56M(+50.2%) | -$54.07M(-23.3%) |
| Dec 2002 | -$24.15M(-4.4%) | -$25.25M(-272.0%) | -$43.85M(-107.3%) |
| Sep 2002 | - | -$6.79M(+28.4%) | -$21.16M(-11.8%) |
| Jun 2002 | - | -$9.47M(-303.7%) | -$18.93M(-10.6%) |
| Mar 2002 | - | -$2.35M(+7.9%) | -$17.12M(+26.0%) |
| Dec 2001 | -$23.14M(+49.6%) | -$2.55M(+44.1%) | -$23.14M(+22.9%) |
| Sep 2001 | - | -$4.56M(+40.5%) | -$30.00M(+16.4%) |
| Jun 2001 | - | -$7.67M(+8.4%) | -$35.88M(+14.1%) |
| Mar 2001 | - | -$8.37M(+11.1%) | -$41.79M(+7.1%) |
| Dec 2000 | -$45.88M(+18.5%) | -$9.41M(+9.8%) | -$44.98M(+13.9%) |
| Sep 2000 | - | -$10.44M(+23.1%) | -$52.23M(+8.3%) |
| Jun 2000 | - | -$13.58M(-17.5%) | -$56.93M(+5.4%) |
| Mar 2000 | - | -$11.55M(+30.6%) | -$60.15M(+1.9%) |
| Dec 1999 | -$56.29M(+19.2%) | -$16.66M(-10.1%) | -$61.30M(+10.6%) |
| Sep 1999 | - | -$15.13M(+9.9%) | -$68.53M(+2.5%) |
| Jun 1999 | - | -$16.80M(-32.3%) | -$70.30M(-0.9%) |
| Mar 1999 | - | -$12.70M(+46.9%) | -$69.70M(-0.1%) |
| Dec 1998 | -$69.63M(-125.8%) | -$23.90M(-41.4%) | -$69.60M(-46.2%) |
| Sep 1998 | - | -$16.90M(-4.3%) | -$47.60M(-16.1%) |
| Jun 1998 | - | -$16.20M(-28.6%) | -$41.00M(-19.9%) |
| Mar 1998 | - | -$12.60M(-563.2%) | -$34.20M(-11.4%) |
| Dec 1997 | -$30.84M(+6.2%) | -$1.90M(+81.6%) | -$30.70M(+22.1%) |
| Sep 1997 | - | -$10.30M(-9.6%) | -$39.40M(-9.1%) |
| Jun 1997 | - | -$9.40M(-3.3%) | -$36.10M(-1.4%) |
| Mar 1997 | - | -$9.10M(+14.2%) | -$35.60M(-9.2%) |
| Dec 1996 | -$32.86M(-29.9%) | -$10.60M(-51.4%) | -$32.60M(-10.9%) |
| Sep 1996 | - | -$7.00M(+21.3%) | -$29.40M(+2.3%) |
| Jun 1996 | - | -$8.90M(-45.9%) | -$30.10M(-90.5%) |
| Mar 1996 | - | -$6.10M(+17.6%) | -$15.80M(-14.5%) |
| Dec 1995 | -$25.30M(-21.3%) | -$7.40M(+3.9%) | -$13.80M(-23.2%) |
| Sep 1995 | - | -$7.70M(-242.6%) | -$11.20M(-34.9%) |
| Jun 1995 | - | $5.40M(+231.7%) | -$8.30M(+57.2%) |
| Mar 1995 | - | -$4.10M(+14.6%) | -$19.40M(+7.2%) |
| Dec 1994 | -$20.85M(-46.5%) | -$4.80M(0.0%) | -$20.90M(-29.8%) |
| Sep 1994 | - | -$4.80M(+15.8%) | -$16.10M(-42.5%) |
| Jun 1994 | - | -$5.70M(-1.8%) | -$11.30M(-101.8%) |
| Mar 1994 | - | -$5.60M | -$5.60M |
| Dec 1993 | -$14.23M(-14.0%) | - | - |
| Dec 1992 | -$12.48M | - | - |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual EBIT year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly EBIT year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM EBIT year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual earnings before interest & taxes?
The current annual EBIT of LGND is $23.02M
What is the all-time high annual EBIT for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual earnings before interest & taxes is $163.73M
What is Ligand Pharmaceuticals Incorporated annual EBIT year-on-year change?
Over the past year, LGND annual earnings before interest & taxes has changed by +$13.20M (+134.41%)
What is Ligand Pharmaceuticals Incorporated quarterly earnings before interest & taxes?
The current quarterly EBIT of LGND is $12.38M
What is the all-time high quarterly EBIT for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly earnings before interest & taxes is $851.62M
What is Ligand Pharmaceuticals Incorporated quarterly EBIT year-on-year change?
Over the past year, LGND quarterly earnings before interest & taxes has changed by +$76.50M (+119.30%)
What is Ligand Pharmaceuticals Incorporated TTM earnings before interest & taxes?
The current TTM EBIT of LGND is -$80.85M
What is the all-time high TTM EBIT for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM earnings before interest & taxes is $1.01B
What is Ligand Pharmaceuticals Incorporated TTM EBIT year-on-year change?
Over the past year, LGND TTM earnings before interest & taxes has changed by -$135.40M (-248.21%)